Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI

(SAN)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows:

- pharmaceutical products (84.1%): for the treatment of cardio-vascular diseases, thrombosis, central nervous system disorders (insomnia, multiple sclerosis, epilepsy), cancers, allergies, etc. Moreover, Sanofi-Aventis markets OTC products and generic drugs;

- human vaccines (15.9%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas.

At the end of 2019, the group had 81 production sites throughout the world.

Net sales are distributed geographically as follows: Europe (24.5%), United States (35.3%), Asia (12.2%), Latin America (7.6%), Africa and Middle East (6.4%) and other (14%).

Number of employees : 100 409 people.
Sales per Business
20182019Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals24,68571.6%25,70871.2% +4.14%
Vaccines5,11814.9%5,73115.9% +11.98%
Consumer Healthcare4,66013.5%4,68713% +0.58%
Sales per region
2019
EUR (in Million)%
United States12,75635.3%
Europe6,59118.2%
Asia4,39312.2%
Latin America2,7347.6%
Africa and Middle East2,3076.4%
France2,2616.3%
Japan1,9085.3%
Eurasia1,3123.6%
Rest of the World1,2473.5%
South Korea449.001.2%
Managers
NameAgeSinceTitle
Paul Hudson532019Chief Executive Officer & Director
Serge Weinberg692015Chairman
Jean-Baptiste Chasseloup de Chatillon552018Chief Financial Officer & Executive Vice President
John C. Reed, Dr.62-EVP & Global Head-Research & Development
Nestle Frank-2016Global Head-Immunology Therapeutic Research Area
Dietmar P. Berger, Dr.--Chief Medical Officer & Global Head-Development
Carole Piwnica622011Independent Director
Laurent Attal, Dr.622012Director
Fabienne Lecorvaisier582013Independent Director
Patrick Kron672014Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,256,192,074 1,116,927,806 88.9% 2,590,000 0.2% 88.9%
Shareholders
NameEquities%
L'Oréal S.A. 118,227,307 9.39%
The Vanguard Group, Inc. 33,464,092 2.66%
Norges Bank Investment Management 26,690,482 2.12%
Fidelity Management & Research Co. LLC 22,508,744 1.79%
Plan d'Epargne Entreprise Sanofi Synthelabo 20,371,851 1.62%
Lyxor International Asset Management SAS 15,088,524 1.20%
Dodge & Cox 14,552,709 1.16%
Amundi Asset Management SA (Investment Management) 13,869,395 1.10%
FIL Investment Advisors (UK) Ltd. 10,603,841 0.84%
BNP Paribas Asset Management France SAS 10,486,571 0.83%
Holdings
NameEquities%Valuation
Sanofi India Limited (500674) 13,909,58760.4%1,502,261,685 USD
Sanofi (SAN) 3,101,3360.25%279,506,201 USD
Regeneron Pharmaceuticals (REGN) 279,7660.27%152,069,607 USD
Inozyme Pharma, Inc. (INZY) 520,1252.23%11,947,271 USD
Fulcrum Therapeutics, Inc. (FULC) 558,0352.03%5,502,225 USD
Cogent Biosciences, Inc. (COGT) 842,0481.97%2,593,508 USD
Qualigen Therapeutics, Inc. (QLGN) 79,2090.35%304,163 USD
Markets and indexes
- PEA / SRD eligible : YES / YES
-
- Compartiment A
- CAC 40 / CAC All Shares, CAC All-Tradable, CAC Large 60, Euronext 100, Euro Stoxx 50, FTSE Eurotop 100, Low Carbon 100 Europe, PEA, SBF 120, Stoxx Europe 50, STOXX Europe 600, Stoxx France 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
Company contact information
Sanofi
54 Rue la Boétie
FR-75008 Paris


Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
web site : http://www.sanofi.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Sanofi
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI1.85%127 996
JOHNSON & JOHNSON-1.28%378 244
ROCHE HOLDING AG-3.47%285 939
NOVARTIS AG-11.58%203 854
PFIZER INC.0.30%203 048
MERCK & CO., INC.-11.97%202 555
ABBVIE INC.17.69%183 962
NOVO NORDISK A/S7.27%153 607
BRISTOL-MYERS SQUIBB COMPANY-1.78%142 003
ASTRAZENECA PLC2.14%135 559
ELI LILLY AND COMPANY12.18%131 228
AMGEN INC.-6.74%128 258
GLAXOSMITHKLINE PLC-22.23%92 246
CHUGAI PHARMACEUTICAL CO., LTD.42.95%75 720
DAIICHI SANKYO COMPANY, LIMITED56.60%70 399
JIANGSU HENGRUI MEDICINE CO., LTD.17.92%69 112
BAYER AG-32.00%57 555
TAKEDA PHARMACEUTICAL COMPANY LIMITED-15.03%55 191
ASTELLAS PHARMA INC.-15.08%28 289
HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED36.49%26 995
EISAI CO., LTD.-4.69%21 493